These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7483799)

  • 1. Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus.
    Da Villa G; Picciotto L; Ribera G; Bencivenga M; Cotugno M; Hartmann P
    Vaccine; 1995 Jun; 13(9):795-8. PubMed ID: 7483799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy.
    Giammanco G; Li Volti S; Mauro L; Bilancia GG; Salemi I; Barone P; Musumeci S
    Vaccine; 1991 Oct; 9(10):747-50. PubMed ID: 1836919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous administration of HB recombinant vaccine with diphtheria and tetanus toxoid and oral polio vaccine: a pilot study.
    Barone P; Mauro L; Leonardi S; Ienna M; Giammanco Bilancia G; Falcidia E; Musumeci S
    Acta Paediatr Jpn; 1991 Aug; 33(4):455-8. PubMed ID: 1838852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen.
    Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
    Infect Immun; 1986 Mar; 51(3):784-7. PubMed ID: 2936684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine.
    Hogg K; Hogg G
    Vaccine; 2003 Jun; 21(21-22):2906-10. PubMed ID: 12798634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination.
    Ota MO; Vekemans J; Schlegel-Haueter SE; Fielding K; Sanneh M; Kidd M; Newport MJ; Aaby P; Whittle H; Lambert PH; McAdam KP; Siegrist CA; Marchant A
    J Immunol; 2002 Jan; 168(2):919-25. PubMed ID: 11777990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
    Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
    Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M; Zambrano B; Santos-Lima E
    Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age.
    Arístegui J; Dal-Ré R; Garrote E; González A; Arrate JP; Pérez A
    Vaccine; 1998 Dec; 16(20):1976-81. PubMed ID: 9796053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals.
    Sönmez E; Sönmez AS; Bayindir Y; Coskun D; Aritürk S
    Vaccine; 2002 Dec; 21(3-4):243-6. PubMed ID: 12450699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of hepatitis B antibody response in children immunised with hepatitis B and compulsory vaccines.
    Li Volti S; Giammanco-Bilancia G; Giammanco G; Mollica F
    Eur J Epidemiol; 1995 Apr; 11(2):217-9. PubMed ID: 7672079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
    Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
    J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.